Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.900 | strong | 0.943 | 1 | 0 | 1996 | 2019 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.900 | limited | 0.875 | 1 | 0 | 2002 | 2019 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.900 | None | 0.967 | 1 | 0 | 2006 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.900 | strong | 1.000 | 1 | 0 | 1998 | 2018 | ||||||||
|
pyruvate dehydrogenase E1 subunit alpha 1 | 0.581 | 0.538 | 0.99 |
|
disease | 0.900 | None | 1.000 | 1 | 0 | 1990 | 2015 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
group | 0.900 | definitive | 0.976 | 1 | 0 | 1990 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.900 | strong | 0.948 | 1 | 0 | 1996 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.900 | None | 0.947 | 1 | 0 | 1994 | 2020 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
disease | 0.900 | strong | 0.982 | 1 | 0 | 1981 | 2019 | ||||||||
|
uroporphyrinogen decarboxylase | 0.521 | 0.769 | 1.3E-08 |
|
disease | 0.900 | None | 0.988 | 1 | 0 | 1976 | 2019 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.900 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.900 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
filamin A | 0.419 | 0.846 | 1.00 |
|
disease | 0.810 | strong | 1.000 | 1 | 0 | 1998 | 2013 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.800 | strong | 0.963 | 5 | 0 | 2000 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.800 | None | 1.000 | 2 | 0 | 1997 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.800 | None | 0.957 | 1 | 0 | 1994 | 2019 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.800 | None | 1.000 | 1 | 0 | 1993 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.800 | None | 0.600 | 1 | 0 | 1997 | 2018 | ||||||||
|
FRAS1 related extracellular matrix 2 | 0.566 | 0.577 | 3.6E-11 |
|
disease | 0.800 | strong | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
disease | 0.800 | strong | 0.929 | 1 | 0 | 1996 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.800 | None | 0.931 | 1 | 0 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.800 | None | 0.974 | 1 | 0 | 1990 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
disease | 0.760 | strong | 1.000 | 1 | 0 | 1996 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.740 | None | 1.000 | 1 | 0 | 1992 | 2013 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.740 | None | 1.000 | 1 | 0 | 2004 | 2017 |